Risk of Autoimmune Disease in Research-Identified Cases of Autism Spectrum Disorder: A Longitudinal, Population-Based Birth Cohort Study

Overview

Journal J Dev Behav Pediatr

Specialties Pediatrics
Social Sciences

Date 2024 Feb 16

PMID 38364086

Authors

Veronica R Villarreal

Maja Z Katusic

Scott M Myers

Amy L Weaver

James J Nocton

Robert G Voigt

Affiliations

Soon will be listed here.

Abstract

Objective: Determine the risk of autoimmune disease in research-identified cases of autism spectrum disorder (ASD) compared with referents using a longitudinal, population-based birth cohort.

Methods: ASD incident cases were identified from a population-based birth cohort of 31,220 individuals. Inclusive ASD definition based on DSM-IV-TR autistic disorder, Asperger syndrome, and pervasive developmental disorder, not otherwise specified, was used to determine ASD cases. For each ASD case, 2 age- and sex-matched referents without ASD were identified. Diagnosis codes assigned between birth and December 2017 were electronically obtained. Individuals were classified as having an autoimmune disorder if they had at least 2 diagnosis codes more than 30 days apart. Cox proportional hazards models were fit to estimate the hazard ratio (HR) between ASD status and autoimmune disorder.

Results: Of 1014 ASD cases, 747 (73.7%) were male. Fifty ASD cases and 59 of the 1:2 matched referents were diagnosed with first autoimmune disorder at the median age of 14 and 17.1 years, respectively. ASD cases had increased risk of autoimmune disease compared with matched referents (HR 1.74; 95% confidence interval [CI], 1.21-2.52). The increased risk was statistically significant among male patients (HR 2.01; 95% CI, 1.26-3.21) but not among the smaller number of female subjects (HR 1.38; 95% CI, 0.76-2.50).

Conclusion: This study provides evidence from a longitudinal, population-based birth cohort for co-occurrence of ASD and autoimmune disorders. Thus, children with ASD should be monitored for symptoms of autoimmune disease and appropriate workup initiated.

References

McCarthy M . The "gender gap" in autoimmune disease. Lancet. 2000; 356(9235):1088. DOI: 10.1016/S0140-6736(05)74535-9. View

Wang L, Wang F, Gershwin M . Human autoimmune diseases: a comprehensive update. J Intern Med. 2015; 278(4):369-95. DOI: 10.1111/joim.12395. View

Cortese S, Gabellone A, Marzulli L, Iturmendi-Sabater I, de La Chica-Duarte D, Pique I . Association between autism spectrum disorder and diabetes: systematic review and meta-analysis. Neurosci Biobehav Rev. 2022; 136:104592. DOI: 10.1016/j.neubiorev.2022.104592. View

Comi A, Zimmerman A, Frye V, Law P, Peeden J . Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999; 14(6):388-94. DOI: 10.1177/088307389901400608. View

Melton 3rd L . History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996; 71(3):266-74. DOI: 10.4065/71.3.266. View

Loomes R, Hull L, Mandy W . What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017; 56(6):466-474. DOI: 10.1016/j.jaac.2017.03.013. View

Kohane I, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L . The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One. 2012; 7(4):e33224. PMC: 3325235. DOI: 10.1371/journal.pone.0033224. View

Rydzewska E, Dunn K, Cooper S . Umbrella systematic review of systematic reviews and meta-analyses on comorbid physical conditions in people with autism spectrum disorder. Br J Psychiatry. 2020; 218(1):10-19. DOI: 10.1192/bjp.2020.167. View

Hyman S, Levy S, Myers S . Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics. 2019; 145(1). DOI: 10.1542/peds.2019-3447. View

10.

Beighley J, Matson J, Rieske R, Jang J, Cervantes P, Goldin R . Comparing challenging behavior in children diagnosed with autism spectrum disorders according to the DSM-IV-TR and the proposed DSM-5. Dev Neurorehabil. 2013; 16(6):375-81. DOI: 10.3109/17518423.2012.760119. View

11.

Kim Y, Fombonne E, Koh Y, Kim S, Cheon K, Leventhal B . A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample. J Am Acad Child Adolesc Psychiatry. 2014; 53(5):500-8. PMC: 4058782. DOI: 10.1016/j.jaac.2013.12.021. View

12.

Amador-Patarroyo M, Rodriguez-Rodriguez A, Montoya-Ortiz G . How does age at onset influence the outcome of autoimmune diseases?. Autoimmune Dis. 2011; 2012:251730. PMC: 3238350. DOI: 10.1155/2012/251730. View

13.

Muskens J, Velders F, Staal W . Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review. Eur Child Adolesc Psychiatry. 2017; 26(9):1093-1103. PMC: 5591355. DOI: 10.1007/s00787-017-1020-0. View

14.

Mead J, Ashwood P . Evidence supporting an altered immune response in ASD. Immunol Lett. 2014; 163(1):49-55. DOI: 10.1016/j.imlet.2014.11.006. View

15.

Wu S, Ding Y, Wu F, Li R, Xie G, Hou J . Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2015; 55:322-32. DOI: 10.1016/j.neubiorev.2015.05.004. View

16.

McLeod D, Caturegli P, Cooper D, Matos P, Hutfless S . Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA. 2014; 311(15):1563-5. DOI: 10.1001/jama.2013.285606. View

17.

Myers S, Voigt R, Colligan R, Weaver A, Storlie C, Stoeckel R . Autism Spectrum Disorder: Incidence and Time Trends Over Two Decades in a Population-Based Birth Cohort. J Autism Dev Disord. 2018; 49(4):1455-1474. PMC: 6594832. DOI: 10.1007/s10803-018-3834-0. View

18.

Hossain M, Khan N, Sultana A, Ma P, McKyer E, Ahmed H . Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: An umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 2020; 287:112922. DOI: 10.1016/j.psychres.2020.112922. View

19.

Kirsch A, Huebner A, Mehta S, Howie F, Weaver A, Myers S . Association of Comorbid Mood and Anxiety Disorders With Autism Spectrum Disorder. JAMA Pediatr. 2019; 174(1):63-70. PMC: 6902186. DOI: 10.1001/jamapediatrics.2019.4368. View

20.

Maenner M, Warren Z, Williams A, Amoakohene E, Bakian A, Bilder D . Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ. 2023; 72(2):1-14. PMC: 10042614. DOI: 10.15585/mmwr.ss7202a1. View